182 related articles for article (PubMed ID: 2491609)
21. [An immunohistochemical study on human leucocyte antigen-DR in Hashimoto thyroiditis and Graves disease].
Zhang H; Li D; Ouyang A
Zhonghua Nei Ke Za Zhi; 1996 May; 35(5):303-5. PubMed ID: 9387612
[TBL] [Abstract][Full Text] [Related]
22. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
23. Expression of adhesion molecules on infiltrating T cells in thyroid glands from patients with Graves' disease.
Ishikawa N; Eguchi K; Ueki Y; Nakashima M; Shimada H; Ito K; Nagataki S
Clin Exp Immunol; 1993 Nov; 94(2):363-70. PubMed ID: 7900942
[TBL] [Abstract][Full Text] [Related]
24. Thyroid peroxidase activity-inhibiting immunoglobulins in patients with autoimmune thyroid disease.
Okamoto Y; Hamada N; Saito H; Ohno M; Noh J; Ito K; Morii H
J Clin Endocrinol Metab; 1989 Apr; 68(4):730-4. PubMed ID: 2921308
[TBL] [Abstract][Full Text] [Related]
25. The expression of the microsomal/peroxidase autoantigen in human thyroid cells is thyrotrophin-dependent.
Chiovato L; Vitti P; Cucchi P; Mammoli C; Carajon P; Pinchera A
Clin Exp Immunol; 1989 Apr; 76(1):47-53. PubMed ID: 2661062
[TBL] [Abstract][Full Text] [Related]
26. Development of a human monoclonal antibody from a Graves' disease patient that identifies a novel thyroid membrane antigen.
Baker JR; Saunders NB; Kaulfersch W; Burman KD
J Immunol; 1988 Apr; 140(8):2593-9. PubMed ID: 2895790
[TBL] [Abstract][Full Text] [Related]
27. Subpopulations of intrathyroidal lymphocytes in Graves' disease.
Duh YC; Su IJ; Liaw KY; Yao CC
J Formos Med Assoc; 1990 Feb; 89(2):121-5. PubMed ID: 1973719
[TBL] [Abstract][Full Text] [Related]
28. The in vitro regulation of human thyrocyte HLA-DR antigen expression.
Weetman AP; Volkman DJ; Burman KD; Gerrard TL; Fauci AS
J Clin Endocrinol Metab; 1985 Nov; 61(5):817-24. PubMed ID: 2995430
[TBL] [Abstract][Full Text] [Related]
29. Coexpression of CD40 and class II antigen HLA-DR in Graves' disease thyroid epithelial cells.
Faure GC; Bensoussan-Lejzerowicz D; Bene MC; Aubert V; Leclere J
Clin Immunol Immunopathol; 1997 Aug; 84(2):212-5. PubMed ID: 9245555
[TBL] [Abstract][Full Text] [Related]
30. Effect of HLA-DR positive thyrocytes on in vitro thyroid autoantibody production.
Iwatani Y; Iitaka M; Row VV; Volpé R
Clin Invest Med; 1988 Aug; 11(4):279-85. PubMed ID: 3262474
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of functional and immunological responses to thyroid-stimulating antibodies from patients with Graves' disease by blockade of the thyrotropin receptor.
Hoermann R; Schumm-Draeger PM; Mann K
Thyroid; 1993; 3(4):273-8. PubMed ID: 7906974
[TBL] [Abstract][Full Text] [Related]
32. The effect of adding a surfeit of autologous CD8+ T cells to SCID mice after secondary rexenografts of Graves' thyroid tissue.
Mukuta T; Nishikawa M; Arreaza G; Resetkova E; Yoshikawa N; Fornasier V; Young E; Volpé R
Thyroid; 1996 Oct; 6(5):429-36. PubMed ID: 8936667
[TBL] [Abstract][Full Text] [Related]
33. The effect of dithiotreitol on thyroid peroxidase and microsomal antigen epitopes recognized by auto and monoclonal antibodies.
Gardas A; Domek H; Czarnocka B
Autoimmunity; 1990; 7(2-3):149-56. PubMed ID: 1716478
[TBL] [Abstract][Full Text] [Related]
34. Expression of intercellular adhesion molecule-1 in thyroid follicular cells in autoimmune, non-autoimmune and neoplastic diseases of the thyroid gland: discordance with HLA.
Tolosa E; Roura C; Catálfamo M; Martí M; Lucas-Martín A; Sanmartí A; Salinas I; Obiols G; Foz-Sala M; Pujol-Borrell R
J Autoimmun; 1992 Feb; 5(1):107-18. PubMed ID: 1348415
[TBL] [Abstract][Full Text] [Related]
35. Function of DR-positive thyrocytes from patients with Graves' disease: quantitative analysis of thyroid peroxidase content by fluorescent photometry.
Asakawa H; Hanafusa T; Kuma K; Kono N; Tarui S
J Clin Endocrinol Metab; 1992 Mar; 74(3):614-8. PubMed ID: 1740495
[TBL] [Abstract][Full Text] [Related]
36. Ectopic expression of HLA class II antigens on thyroid follicular cells: induction and transfer in vitro by autologous mononuclear leukocytes.
Khoury EL; Greenspan JS; Greenspan FS
J Clin Endocrinol Metab; 1988 Nov; 67(5):992-1004. PubMed ID: 2972740
[TBL] [Abstract][Full Text] [Related]
37. In vitro cellular interactions among thyrocytes, T cells and monocytes from patients with Graves' disease.
Otsubo T; Eguchi K; Shimomura C; Ueki Y; Tezuka H; Ishikawa N; Ito K; Nagataki S
Acta Endocrinol (Copenh); 1988 Mar; 117(3):282-8. PubMed ID: 3132793
[TBL] [Abstract][Full Text] [Related]
38. Tissue specificity and serologic reactivity of an autoantigen associated with autoimmune thyroid disease.
Ross PV; Koenig RJ; Arscott P; Ludgate M; Waier M; Nelson CC; Kaplan MM; Baker JR
J Clin Endocrinol Metab; 1993 Aug; 77(2):433-8. PubMed ID: 8345048
[TBL] [Abstract][Full Text] [Related]
39. Effects of recombinant human interleukin-2 and tumor necrosis factor-alpha with or without interferon-gamma on human thyroid tissues from patients with Graves' disease and from normal subjects xenografted into nude mice.
Kasuga Y; Matsubayashi S; Akasu F; Miller N; Jamieson C; Volpé R
J Clin Endocrinol Metab; 1991 Jun; 72(6):1296-301. PubMed ID: 1902846
[TBL] [Abstract][Full Text] [Related]
40. Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity.
Hanafusa T; Pujol-Borrell R; Chiovato L; Russell RC; Doniach D; Bottazzo GF
Lancet; 1983 Nov; 2(8359):1111-5. PubMed ID: 6138646
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
